Fibropapillomatosis (FP) is a neoplastic disease that affects marine turtles worldwide, especially green sea turtles (Chelonia mydas). FP tumors can develop on the body surface of marine turtles and also internally in the oral cavity and viscera. Depending on their quantity, size and anatomical distribution, these tumors can interfere with hydrodynamics and the ability to feed, hence scoring systems have been proposed in an attempt to quantify the clinical manifestation of FP. In order to establish a new scoring system adapted to geographic regions, we examined 214 juvenile green sea turtles with FP caught or rescued at Brazilian feeding areas, counted their 7466 tumors and classified them in relation to their size and anatomical distribution. The patterns in quantity, size and distribution of tumors revealed interesting aspects in the clinical manifestation of FP in specimens studied in Brazil, and that FP scoring systems developed for other areas might not perform adequately when applied to sea turtles on the Southwest Atlantic Ocean. We therefore propose a novel method to evaluate the clinical manifestation of FP: fibropapillomatosis index (FPI) that provides the Southwest Atlantic fibropapillomatosis score (FPSSWA). In combination, these indexing and scoring systems allow for a more objective, rapid and detailed evaluation of the severity of FP in green sea turtles. While primarily designed for the clinical manifestation of FP currently witnessed in our dataset, this index and the score system can be adapted for other areas and compare the characteristics of the disease across regions. In conclusion, scoring systems to classify the severity of FP can assist our understanding on the environmental factors that modulate its development and its impacts on the individual and population health of green sea turtles.
Citation: Rossi S, Sánchez-Sarmiento AM, Vanstreels RET, dos Santos RG, Prioste FES, Gattamorta MA, et al. (2016) Challenges in Evaluating the Severity of Fibropapillomatosis: A Proposal for Objective Index and Score System for Green Sea Turtles (Chelonia mydas) in Brazil. PLoS ONE 11(12): e0167632. https://doi.org/10.1371/journal.pone.0167632
Editor: Christopher D. Marshall, Texas A&M University at Galveston, UNITED STATES
Received: June 7, 2016; Accepted: November 17, 2016; Published: December 9, 2016
Copyright: © 2016 Rossi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This work was supported by: Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP (www.fapesp.br): process number 2009/53956-9 (RETV), 2010/01781-8 (SR), 2011/04565-7 (AMSS), 2012/14319-6 (ERM); Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-CAPES (www.capes.gov.br): RGS, FESP, MAG.
Competing interests: The authors have declared that no competing interests exist.
Green sea turtles (Chelonia mydas) have a global tropical and subtropical distribution, and spend most of their lives in coastal areas foraging on seagrass and macroalgae [1,2]. Besides fisheries bycatch, habitat destruction and pollution, green sea turtles are threatened by fibropapillomatosis (FP) [3,4]. This neoplastic disease is included in the list of priority research questions based on the opinions of sea turtle researchers who work in fields related to conservation and/or turtle biology . FP tumors were transmissible in experimental studies, and there is consensus that the Chelonid herpesvirus 5 (ChHV5) plays a central role in its pathogenesis [6–9]. However, the host immune response and genetic and environmental cofactors may also be involved in determining the development and clinical manifestation of the disease [10–12], and green sea turtles with many tumors can act as superspreaders in the ocean . In a study in Brazilian coast with 175 fibropapillomas collected from 139 green turtles, the presence of ChHV5 was detected and quantified in 153 samples of FP tumors collected (87% were positive by qPCR) and revealed that 73% of them were positive for ChHV5 in conventional polymerase chain reaction (PCR) . Phylogenetic analysis of ChHV5 variants have revealed four phylogeographical groups: eastern Pacific, western Atlantic/eastern Caribbean, mid-west Pacific and Atlantic , and other researchers have detected different local or regional variants, suggesting that infection occurs locally after recruitment into coastal foraging areas [9,14,16,17].
FP has a circumtropical distribution and seems most frequent in sea turtles at coastal feeding grounds, often in areas heavily impacted by human activities [9,18,19]. The disease was first described in 1938 in green sea turtles from Florida, USA . In Brazil, it was first documented in 1986 at Espírito Santo state, and since then it has been reported throughout most of the country’s coastline .
Depending on their size, number and anatomical position, FP tumors can interfere with locomotion, food ingestion, growth, reproduction, vision, and the ability to avoid predators [22–24]. FP tumors can develop on the body surface of marine turtles, including the carapace, cornea, and plastron (where tumors develop in the sutures between the scutes), and also internally in the oral cavity, esophagus, heart, lungs, liver, spleen, kidneys, gastrointestinal system, and skeletal muscles [22,25–27]. While oropharyngeal and visceral tumors have been reported and are relatively common in green sea turtles with FP in Hawaii [26,27], they seem much less common in specimens captured in Florida [25,28] and are very rare in Brazil, where most tumors have been reported on the limbs [21,29–31].
Some studies have demonstrated that the clinical presentation of FP may be related to an individual’s growth rate, sex, parasite infestation and hematology [22,32–34], and the use of scoring systems to classify the severity of FP can assist our understanding on the environmental factors that modulate its development . For this purpose, past studies have attempted to classify FP through the subjective visual inspection of specimens or of dorsal and ventral photographs [4,35,36] or through objective scoring systems based on the number of tumors and their anatomical distribution, categories of size and an estimative of the total area of tumors [22,25,27,32,33]. Among the attempts to classify FP, there is a system that uses number of tumors and tumor size category to assign a score of FP severity, which was developed using FP manifestation found in green sea turtles studied in Hawaii and has been broadly used by sea turtle conservation programs .
Because of a geographic variation in FP manifestation, the score system proposed by Work & Balazs (1999)  was not meant to be universal, being appropriate for the green sea turtles found in Hawaii. So, in order to reduce subjectivity and provide a more comprehensive framework to evaluate the severity and clinical manifestation of FP, the aim of this study was to develop a fibropapillomatosis index (FPI) and a new FP score system: the Southwest Atlantic fibropapillomatosis score (FPSSWA). They are herein proposed based on three aspects: (1) keeping it simple and easy-to-use; (2) to have a good correlation with total tumor area and (3) to achieve an index and a score that better assess FP manifestation in green turtles found in Brazil.
Materials and Methods
Between 2005 and 2014, 214 juvenile green sea turtles with FP (curved carapace length ranging from 30.5 to 68.5 cm; body mass ranging from 2.6 to 35 kg) were caught or rescued along the coast of five states on the Brazilian coast: São Paulo (n = 72), Rio de Janeiro (n = 1), Espírito Santo (n = 133), Bahia (n = 4) and Ceará (n = 4) according to monitoring of Projeto TAMAR. For each examined individual, FP tumors were counted and classified into four size categories based on their diameter: A (<1 cm), B (1–4 cm), C (>4–10 cm) and D (>10 cm) . Tumors of each size category were counted separately for each of eleven anatomical regions (Fig 1): left eye, right eye, head, neck, left forelimb, right forelimb, carapace, plastron, left hindlimb, right hindlimb, inguinal region/tail. Of the 214 individuals examined in the study, 124 were dead and were also examined for internal tumors: Espírito Santo (n = 113), São Paulo (n = 7) and Bahia (n = 4). For each individual, the total number of tumors (all anatomical regions combined) was calculated for each size category (NA, NB, NC and ND; N = number of tumors in each size category A-D), as well as the total number of tumors in all size categories (Nall). This study agreed with the Ethical Principles in Animal Research adopted by Ethic Committee in the use of animals (Comissão de Ética no Uso de Animais) of the Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo (697/2005, 1932/2010, 2116/2010 and 2555/2012) and was approved by the Instituto Chico Mendes de Conservação da Biodiversidade (ICMBio)–Ministério do Meio Ambiente, Brazil (SISBIO 22751, 26667, 21802 and 32636).
Percentages relate to the total number of tumors evaluated in the study (n = 7466). Drawing adapted from Pritchard & Mortimer (1999) .
When we attempted to apply Work and Balazs’ classification scheme  to our dataset, 73% (156/214) of the studied individuals could not be classified as they fell outside the boundaries of the score categories. This is probably due to the differences in FP manifestation between turtles found in Hawaii and Brazil. An adapted version of this classification was developed, which we will refer to as the Hawaii fibropapillomatosis score (FPSHWI), based on three rules: (a) if an individual has no C-sized or D-sized tumors (i.e. NC = 0 and ND = 0) and it has five or less tumors size A and five or less tumors size B (i.e. NA ≤ 5 and NB ≤ 5), it is classified as ‘mild’; (b) if an individual has one or more D-category tumors and/or if it has four or more C-sized tumors (i.e. ND ≥ 1 and/or NC ≥ 4), it is classified as ‘severe’; (c) if an individual cannot be classified by the previous two rules, it is classified as ‘moderate’.
Additionally, we incorporated data from Rossi et al. (2009)  on the total tumor area (TTA) of 27 juvenile green sea turtles (a subset of the individuals examined in this study). TTA had been calculated estimating the cross-sectional area (cm2) of each individual tumor using the formula: π × 0.5a × 0.5b for the major [a] and minor [b] axis of an ellipse . For the subset of animals for which the TTA was calculated, we performed a multiple linear regression analysis to evaluate how TTA is related to the number of tumors in each size category (NA, NB, NC, and ND). Since we sought an index that was highly correlated with TTA and simplification is a key factor to a wider use, the fitted model was then simplified by rounding its coefficients to obtain the FPI formula. After FPI was calculated for all animals, we assessed its correlation with TTA (which should be high, considering that FPI is based directly on the size classification) through linear regression. We estimated the best cut-offs for transforming this continuous variable into an ordinal one (thus creating a score for FP manifestation, the FPSSWA) by analyzing the scatter plot of the relationship between TTA and FPI.
In order to test which score system (FPSSWA or FPSHWI) performed better in assessing FP manifestation in green sea turtles found in Brazil, we tested both in another subset of animals, for which an expert-based score system was implemented. A subjective fibropapillomatosis score (FPSSBJ) was obtained by having five researchers evaluating dorsal and ventral photographs of 52 green sea turtles (13 specimens studied in São Paulo State and 39 in Espírito Santo State), then reach a consensus to classify each sea turtle into one of three subjective categories of FP severity: ‘mild’, ‘moderate’ or ‘severe’.
The weighted Kappa statistic  was used to evaluate the agreement between these different scoring systems (FPSSBJ, FPSHWI, FPSSWA). Significance level (alpha) was 0.05 for all tests. The raw data, on which the analyses are based, are provided in S1 File. Statistical analyses were made with R software  and Weighted Kappa was calculated with the “irr” R package .
A total of 7466 tumors were counted, ranging between 1 and 129 tumors per individual. Most tumors were on the limbs, with 45% on the forelimbs, 34% on the hindlimbs, 10% on the neck, and 10% in the remaining areas of the body. Table 1 and Fig 1 detail the anatomical distribution of the tumors. Three of the studied specimens that were necropsied had tumors in the oral cavity and esophagus (size categories A and B, not included in statistical analyses).
Fibropapillomatosis index (FPI)
The relationship between TTA and the number of tumors in each size category (NA, NB, NC, and ND) was analyzed with multiple linear regression resulting in the following function: TTA = 0.031 + 0.056 × NA + 1.172 × NB + 22.161 × NC + 36.198 × ND (R2 = 93.85%). We simplified this result to obtain the following function for our proposed index: FPI = 0.1 × NA + 1 × NB + 20 × NC + 40 × ND. In order to assess the correlation between FPI and TTA, we fitted a linear model with regression analysis, obtaining the following regression: TTA = 0.16 + 1.11 × FPI (R2 = 93.7%) (Fig 2). Considering that FPI is based directly on the size classification (taking into account only the highest dimension between length and width) and TTA is calculated with the area of each tumor, it was expected a strong correlation between them. Therefore, our proposed index was not only highly correlated with TTA, but it also made possible to have a good estimate of TTA based on FPI using the previous formula (which is much simpler than measuring each tumor individually to calculate TTA directly).
Southwest Atlantic Fibropapillomatosis Score (FPSSWA)
Based on FPI, the FPSSWA is proposed, wherein an individual is classified as ‘mild’ (FPI < 40), ‘moderate’ (40 ≤ FPI < 120), or ‘severe’ (FPI ≥ 120). Fig 3 shows how this score system performs in discriminating TTA from turtles on the coast of Brazil when compared to FPSHWI.
Data obtained from 27 juvenile green sea turtles at select localities along the coast of Brazil.
To further evaluate score systems, we calculated the weighted Kappa coefficient between FPSSWA and FPSHWI with FPSSBJ. This validation was made in a different subset of green sea turtles (n = 52) than the subset used previously to study TTA. FPSSBJ and FPSHWI had moderate agreement (κ = 50.3%), with most of disagreement being related to individuals that were classified as mild by FPSSBJ but as moderate by FPSHWI (17 of 28 disagreements). FPSSBJ and FPSSWA had substantial agreement (κ = 72.9%), with most of disagreement being related to individuals that were classified as mild by FPSSBJ but as moderate by FPSSWA (5 of 18 disagreements) and that were classified as moderate by FPSSBJ but as severe by FPSSWA (5 of 18 disagreements). This suggests that, for juvenile green turtles in Brazil, FPSSWA had a higher agreement with the experts’ subjective assessment of FP manifestation severity than FPSHWI.
Size, number, anatomical distribution and other features of tumors
The total number of tumors varied considerably among specimens (range 1 to 129) and most of them were relatively small, being classified in the size categories A and B (i.e. smaller than 4 cm). Analysis according to size classification of tumors revealed that the average per affected turtle was 8.7±6.8 and 79% of FP-green sea turtles had more than ten tumors. Studies in Indonesia with 4407 green sea turtles (949 with FP tumors) revealed an average of 5±4.1 tumors per individual (range 1 to 29) and only 12.6% had more than ten tumors .
The FP tumors exhibited varied morphology, color and texture (smooth to verruciform), as documented in previous studies in Brazil . Most tumors were on the limbs, results consistent with previous studies on green sea turtles in Brazil [21,30,31] and southeastern USA . In Hawaii, tumors are predominantly located in the anterior areas of the body, including the eyes and inside the oral cavity [25–27]. Previous studies found that the histopathological characteristics of tumors may depend on their anatomical positioning . Additionally, unusual histopathological presentations such as renal myxofibromas and cutaneous fibromas have also been documented in some instances [28,42].
Challenges in quantifying tumors and scoring fibropapillomatosis
In order to study the differences in the clinical manifestations of FP and in the size and distribution of tumors, methods allowing for the quantification and qualification of the disease are necessary. The simplest approach to evaluate the severity of FP is to subjectively classify it as ‘absent’, ‘mild’, ‘moderate’ or ‘severe’ based on the visual inspection of specimens or of dorsal and ventral photographs [4,35,36]. Wood & Wood (1993)  proposed the first approach to objectively classify in four scores (grades ‘0’, ‘1’, ‘2’ or ‘3’; with ‘0’ corresponding to the absence of cutaneous FP tumors) based on the maximum size of the tumors and having an additional score level (grade ‘4’) for individuals with tumors that physically hampered movement or caused blindness. More recently, researchers have proposed an alternative classification system that combines the number, size range, location, external morphology and external/internal distribution of tumors to classify green sea turtles into four scores (grades ‘0’, ‘1’, ‘2’ or ‘3’) [34,44].
An alternative approach was developed classifying tumors into four categories depending on their size, and then using the number of tumors in each size category to objectively classify FP . This approach was developed despite some degree of subjectivity and it is considered a reliable index of physiological effects of FP [45,46] and has been broadly used [19,27,31,47]. In parallel, several researchers proceeded to count and describe the anatomical distribution of tumors, especially when they occurred internally [22,25–27]. More recently, studies in Brazil measured each tumor individually and then used these measurements to estimate the total area of tumors for each individual, a method that provided a quantitative index to represent the severity of FP . However, because counting and measuring tumors can be time-consuming in some cases, which may not be compatible with field conditions or animal welfare constraints, simplified methods are necessary to allow for rapid but representative assessment of the size, quantity and distribution of tumors.
In this study, we examined a dataset that combined this four-category size classification proposed by Work and Balazs (1999)  with an eleven-category anatomical distribution classification. Obtaining data with this level of detail proved logistically feasible and practical in the field while also providing valuable data for in depth analyses of the clinical manifestations of FP.
The classification system proposed by Work & Balazs (1999)  was not meant to be universal, and while it was appropriate for the green sea turtles in Hawaii, problems arise when we attempted to apply it to the same species in the Southwest Atlantic. Our statistical analysis demonstrated that 73% of the studied specimens could not be classified according to Work & Balazs system . When this system was adapted in a manner to allow it to classify all individuals in our dataset, it produced poor agreement with other classification schemes. This is likely the result of the differences in the clinical manifestations of FP between study sites, with green sea turtles in Brazil generally presenting a large number of small tumors whereas in Hawaii they have less numerous but larger tumors.
As a result, in this study we developed and propose a new approach to classify the severity of FP, a fibropapillomatosis index (FPI) based on a weighted sum model that considers the size category and number of tumors. This function can then be used to classify individuals into three ordinal categories of FP severity, the FPSSWA, which has substantial agreement with subjective assessments of the severity of FP. The function used to calculate FPI is simple and can be readily calculated in the field, and the FPSSWA classification system is similarly practical. This information is summarized in the S2 File.
Lastly, it is worth noting that FPI and FPSSWA can be readily applied to data from sea turtles studied in other regions of the world. Furthermore, if necessary the function parameters and the score system thresholds can also be easily adjusted to better reflect regional differences in FP manifestation, whilst maintaining a consistent standard of data collection to allow for inter-regional comparisons.
Our results emphasize the need for studies thoroughly describing and quantifying the number, size and anatomical distribution of FP tumors in sea turtles. Understanding these quantitative and qualitative aspects will be critical to better understand the pathogenesis of FP and the factors that modulate the development of tumors and their impacts on individual health, and to compare the clinical manifestation of FP among different geographic regions. The objective indexing/scoring approaches herein proposed provide a simple yet detailed framework for data collection and analysis of the clinical manifestations of FP, allowing for a classification of FP that tends to be less influenced by observer bias or experience than subjective scores.
We would like to thank to Projeto TAMAR-ICMBio, Instituto Chico Mendes de Conservação da Biodiversidade (ICMBio) and Comissão de Ética no Uso de Animais (FMVZ-USP). We are indebted to José Luiz Catão-Dias, Jorge Oyakawa and Ticiana Zwarg. Financial support was provided by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2010/01781-8, 2011/04565-7, 2012/14319-6) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).
- Conceptualization: SR AMSS RGS.
- Data curation: SR RETV JHHGF.
- Formal analysis: RETV JHHGF.
- Funding acquisition: ERM.
- Investigation: SR AMSS RGS FESP MAG ERM.
- Methodology: SR AMSS RGS RETV JHHGF.
- Project administration: ERM.
- Resources: SR AMSS RGS ERM.
- Software: RETV JHHGF.
- Supervision: ERM.
- Validation: SR AMSS RETV RGS FESP JHHGF ERM.
- Visualization: SR AMSS RETV RGS FESP MAG JHHGF ERM.
- Writing – original draft: SR AMSS RETV RGS FESP MAG JHHGF ERM.
- Writing – review & editing: SR AMSS RETV RGS FESP MAG JHHGF ERM.
- 1. Hirth HF. Synopsis of the biological data on green turtle Chelonia mydas (Linnaeus, 1758). In: Biological Report. Fish and Wildlife Service: Washington; 1997.
- 2. Spotila JR. Sea turtles: a complete guide to their biology, behaviour and conservation. Baltimore: The Johns Hopkins University Press, 2004. 227 p.
- 3. Bugoni L, Krause L, Petry MV. Marine debris and human impacts on sea turtles in southern Brazil. Marine Pollution Bulletin. 2001; 42(12): 1330–1334. pmid:11827120
- 4. Hirama S, Ehrhart L. Description, prevalence and severity of green turtle fibropapillomatosis in three developmental habitats on the east coast of Florida. Biological Sciences. 2007; 70(4): 435–448.
- 5. Hamann M, Godfrey M, Seminoff J, Arthur K, Barata P, Bjorndal K., et al. Global research priorities for sea 849 turtles: Informing management and conservation in the 21st century. Endangered Species Research. 2010; 11: 245–269.
- 6. Herbst LH, Jacobson ER, Moretti R, Brown T, Sundberg JP. Experimental transmission of green turtle fibropapillomatosis using cell-free tumor extracts. Dis Aquat Org. 1995; 22: 1–12.
- 7. Lackovich JK, Brown DR, Homer BL, Garber RL, Mader DR, Moretti RH, Patterson AD, Herbst LH, Oros J, Jacobson ER, Curry SS, Klein PA. Association of herpesvirus with fibropapillomatosis of the green turtle Chelonia mydas and the loggerhead turtle Caretta caretta in Florida. Diseases of Aquatic Organisms. 1999;37:89–97. pmid:10494499
- 8. Quackenbusch SL, Casey RN, Murcek RJ, Paul TA, Work TM, Limpus CJ, Chaves A, Dutoit L, Vasconcelos Peres J, Aguirre AA, Spraker RT, Horrocks JA, Vermeer LA, Balazs GH, Casey JW. Quantitative analysis of herpesvirus sequences from normal tissue and fibropapillomas of marine turtles with real time PCR. Virology. 2001; 287: 105–111. pmid:11504546
- 9. Ene A, Su M, Lemaire S, Rose C, Schaff S, Moretti R, et al. Distribution of chelonid fibropapillomatosis associated herpesvirus variants in Florida: molecular genetic evidence for infection of turtles following recruitment to neritic developmental habitats. Journal of Wildlife Diseases. 2005; 41(3): 489–497. pmid:16244058
- 10. Herbst LH, Klein PA. Green turtle fibropapillomatosis: challenges to assessing the role of environmental cofators. Environmental Health Perspectives. 1995; 103(4): 27–30.
- 11. Work TM, Dagenais J, Balazs GH, Schumacher J, Lewis TD, Leong JC, et al. In vitro biology of fibropapilloma-associated turtle herpesvirus and host cells in Hawaiian green turtles (Chelonia mydas). Journal of General Virology. 2009; 90: 1943–1950. pmid:19386781
- 12. van Houtan KS, Hargrove SK, Balazs GH. Land use, macroalgae, and a tumor-forming disease in Marine Turtles. Plos One. 2010; 5(9): 1–8.
- 13. Work TM, Dagenais J, Balazs GH, Schettle N, Ackermann M. Dynamics of Virus Shedding and In Situ Confirmation of Chelonid Herpesvirus 5 in Hawaiian Green Turtles With Fibropapillomatosis. Veterinary Pathology Online First. 2014; 1–8.
- 14. Rodenbusch CR, Baptistotte C, Werneck MR, Pires TT, Melo MTD, Ataíde MW et al. Fibropapillomatosis in green turtles Chelonia mydas in Brazil: characteristics of tumors and virus. Dis Aquat Org. 2014; 111: 207–217. pmid:25320033
- 15. Patrıcio AR, Herbst LH, Duarte A, Velez-Zuazo X, Santos Loureiro N, Pereira N, Tavares L, Toranzos GA. Global phylogeography and evolution of chelonid fibropapilloma-associated herpesvirus. Journal of General Virology. 2012; 93: 1035–1045. pmid:22258862
- 16. Herbst LH, Ene A, Su M, Desalle R, Lenz J. Tumor outbreaks in marine turtles are not due to recent herpesvirus mutations. Current Biology. 2004; 14: R697–R699. pmid:15341757
- 17. Alfaro-Núñez A, Frost Bertelsen M, Miki Bojesen A, Rasmussen I, Zepeda-Mendoza L, Olsen MT, Gilbert MTP. Global distribution of Chelonid fibropapilloma-associated herpesvirus among clinically healthy sea turtles. BMC Evolutionary Biology. 2014; 14 (206): 1–11.
- 18. Aguirre AA, Lutz PL. Marine Turtles as Sentinels of Ecosystem Health: Is Fibropapillomatosis an Indicator? EcoHealth. 2004; 1: 275–283.
- 19. Chaloupka M, Balazs GH, Work TM. Rise and Fall over 26 Years of a Marine Epizootic in Hawaiian Green Sea Turtles. Journal of Wildlife Diseases. 2009; 45(4): 1138–1142. pmid:19901386
- 20. Smith GM, Coates CW. Fibro-epithelial growths of the skin in large marine turtles Chelonia mydas. Zoologica. 1938; 23: 93–98.
- 21. Baptistotte C. Caracterização espacial e temporal da fibropapilomatose em tartarugas marinhas da costa brasileira. PhD Thesis. Escola Superior de Agricultura Luiz de Queiroz–Centro de Energia Nuclear na Agricultura, Universidade de São Paulo. 2007.
- 22. Adnyana W, Ladds PW, Blair D. Observations of fibropapillomatosis in green turtles (Chelonia mydas) in Indonesia. Australian Veterinary Journal. 1997; 75(10): 737–742.
- 23. George RH. Health problems and diseases of sea Turtles. In: Lutz PL, Musick JA, editors. The Biology of Sea Turtles Volume I. Boca Raton, USA: CRC Press; 1997. pp. 363–385.
- 24. Herbst LH, Greiner EC, Ehrhart LM, Bagley DA, Klein PA. Serological association between spirorchidiasis, herpesvirus infection, and fibropapillomatosis in green turtles from Florida. J Wild Dis. 1998; 34(3): 496–507.
- 25. Balazs GH, Aguirre AA, Murakawa SKK. Occurrence of oral fibropapillomas in the Hawaiian green turtle: differential disease expression. Marine Turtle Newsletter. 1997; 76:1–2.
- 26. Aguirre AA, Spraker TR, Balazs GH, Zimmerman B. Spirorchids and fibropapillomas in green turtles from the Hawaiian Islands. Journal of Wildlife Diseases. 1998; 34(1): 91–98. pmid:9476230
- 27. Work TM, Balazs GH, Rameyer RA, Morris RA. Retrospective pathology survey of green turtles Chelonia mydas with fibropapillomatosis in the Hawaiian Islands, 1993–2003. Diseases of Aquatic Organisms. 2004; 62: 163–176. pmid:15648843
- 28. Norton TM, Jacobson ER, Sundberg JP. Cutaneous fibropapillomas and renal myxofibroma in a green turtle, Chelonia mydas. Journal of Wildlife Diseases. 1990; 26(2): 265–270. pmid:2338730
- 29. Brito FLC, Maia FCL, De França LMO, Albuquerque AB, Santos RAM, Cavalcanti MAM, et al. Fibropapillomatosis and multiple fibromas in a green turtle from the South Coast of Pernambuco State, Brazil. Marine Turtle Newsletter. 2004; 106: 12.
- 30. Mascarenhas R, Iverson PJ. Fibropapillomatosis in Stranded Green Turtles (Chelonia mydas) in Paraiba State, Northeastern Brazil: Evidence of Brazilian Epizootic? Marine Turtle Newsletter. 2008; 120: 3–6.
- 31. Santos RG, Martins AS, Torezani E, Baptistotte C, Farias JN, Horta PA et al. Relationship between fibropapillomatosis and environmental quality: a case study with Chelonia mydas off Brazil. Diseases of Aquatic Organisms. 2010; 89: 87–95 pmid:20391916
- 32. Work TM, Balazs GH. Relating tumor score to hematology in green turtles with fibropapillomatosis in Hawaii. Journal of Wildlife Diseases. 1999; 35(4): 804–807. pmid:10574546
- 33. Rossi S, Zwarg T, Sanches TC, Cesar MO, Werneck MR, Matushima ER. Hematological profile of Chelonia mydas (Testudines, Cheloniidae) according to the severity of fibropapillomatosis or its absence. Pesquisa Veterinária Brasileira. 2009; 29(12): 974–978.
- 34. Page-Karjian A, Norton TM, Krimer P, Groner M, Nelson SE, Gottdenker NL. Factors influencing survivorship of rehabilitating green sea turtles (Chelonia mydas) with fibropapillomatosis. Journal of Zoo and Wildlife Medicine. 2014; 45(3): 507–519. pmid:25314817
- 35. Balazs GH. Current status of fibropapillomas in the Hawaiian green turtle, Chelonia mydas. In: Balazs GH, Pooley SG (Ed.). Research plan for marine turtle fibropapilloma. Honolulu: U.S. Department of Commerce, National Oceanographic and Atmospheric Administration, National Marine Fisheries Service. 1991. p. 47–57. (NOAATM-NMFS-SWFSC, 156).
- 36. Borrowman KM. Prevalence and severity of fibropapillomatosis in juvenile green turtles (Chelonia mydas) in three habitats on Florida's East coast. College of Sciences, University of Central Florida, USA. 2008.
- 37. Pritchard PCH, Mortimer JA. Taxonomía, morfología externa e identificación de las espécies. In: Eckert KL, Bjordnal KA, Abreu-Grobois FA, Donnelly M, editors. Técnicas de investigación y manejo para la conservación de las tortugas marinas. Washington: IUCN/SSC Marine Turtle Specialist Group. 2000; pp. 23–44.
- 38. Cohen J. Weighted kappa: Nominal scale agreement with provision for scaled disagreement or partial credit. Psychological Bulletin. 1968; 70(4): 213–220. pmid:19673146
- 39. R Core Team (2016). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org.
- 40. Matthias Gamer, Jim Lemon and Ian Fellows Puspendra Singh (2012). irr: Various Coefficients of Interrater Reliability and Agreement. R package version 0.84. https://CRAN.R-project.org/package=irr.
- 41. Zwarg T, Rossi S, Sanches TC, Cesar MO, Werneck MR, Matushima ER. Hematological and histopathological evaluation of wildlife green turtles (Chelonia mydas) with and without fibropapilloma from the north coast of São Paulo State, Brazil. Pesquisa Veterinária Brasileira. 2014; 34(7):682–688.
- 42. Tapia AC. Evaluación histopatológica de las etiologías comunes y asociadas a fibropapiloma en la tortuga prieta (Chelonia mydas agassizii) de Bahía Magdalena, Baja California Sur, México. PhD Thesis. Centro de Investigaciones Biológicas de Noroeste, La Paz. 2004.
- 43. Wood F, Wood J. Release and recapture of captive-reared green sea turtles, Chelonia mydas, in the waters surrounding Cayman Islands. Herpetological Journal. 1993; 3(3): 84–89.
- 44. Page-Karjian A, Norton TM, Harms C, Mader D, Herbst LH, Stedman N, Gottdenker NL. Case descriptions of fibropapillomatosis in rehabilitating loggerhead sea turtles Caretta caretta in Southeastern USA. Diseases of Aquatic Organisms. 2015; 115: 185–191. pmid:26290503
- 45. Aguirre AA, Balazs GH. Blood biochemistry values of green turtles, Chelonia mydas, with and without fibropapillomatosis. Comparative Haematology International. 2000; 10:132–137
- 46. Work TM., Balazs GH., Wolcott M, Morris RA. Bacteraemia in free-ranging Hawaiian green turtles Chelonia mydas with fibropapillomatosis. Diseases of Aquatic Organisms. 2003; 53, 41–46. pmid:12608567
- 47. Torezani E, Baptistotte C, Mendes SR, Barata PCR. Juvenile green turtles (Chelonia mydas) in the effluent discharge channel of a steel plant, Espírito Santo, Brazil, 2000–2006. Journal of Marine Biological Association of United Kingdom. 2010; 90(2): 233–246.